首页 > 最新文献

BMC Rheumatology最新文献

英文 中文
Environmental pollution impact on the severity of some rheumatic diseases: a comparative analytical study on inflammatory and non-inflammatory samples. 环境污染对某些风湿病严重程度的影响:对炎症和非炎症样本的比较分析研究。
IF 2.1 Q3 RHEUMATOLOGY Pub Date : 2024-10-08 DOI: 10.1186/s41927-024-00420-8
Adel Elbeialy, Soaad El Sawy, Hala Elzomor, Rana Haddad

Objective: Environmental pollution of heavy metals is increasingly a problem and has become of great concern due to the adverse effects it causes worldwide. Heavy metal exposure has been implicated in health problems, including fibromyalgia and rheumatoid arthritis. We aim to evaluate the rule of chronic heavy metals toxicity on the induction of vitamin D3 (VD) deficiency and parathyroid hormone (PTH) disturbances in an inflammatory disease like rheumatoid arthritis (RA) and non-inflammatory disease like fibromyalgia syndrome (FMS).

Methods: This comparative analytical study was conducted on sixty adults (age ≥ 18 years). Participants were divided into three groups. Group I: twenty patients diagnosed with RA according to the specific ACR/EULAR criteria for RA. Group II: twenty patients diagnosed with FMS according to the specific 2010 (ACR) criteria for FMS. Group III: twenty healthy adults. All patients and controls were subjected to routine laboratory tests as well as the measurement of PTH, VD and estimation of serum levels of lead, cadmium, and chromium.

Results: VD was significantly inversely correlated to PTH, lead, cadmium, chromium, and activity scores in the RA and FMS groups. Lead, Cadmium and Chromium had a significant independent risk on the VD level in RA patients, while lead had a significant independent risk on the VD level in FMS patients.

Conclusion: Heavy metals may affect VD synthesis, leading to hypovitaminosis D and secondary hyperparathyroidism in RA and FMS patients. Heavy metals play a key role in the pathogenesis of RA, FMS, and their disease activity.

目的:重金属环境污染问题日益严重,在全球范围内造成的不良影响已引起人们的极大关注。重金属暴露与纤维肌痛和类风湿性关节炎等健康问题有关。我们的目的是评估慢性重金属毒性对诱发类风湿性关节炎(RA)等炎症性疾病和纤维肌痛综合征(FMS)等非炎症性疾病中维生素 D3(VD)缺乏和甲状旁腺激素(PTH)紊乱的影响:这项比较分析研究以 60 名成年人(年龄≥ 18 岁)为对象。参与者分为三组。第一组:20 名根据 ACR/EULAR RA 特定标准诊断为 RA 的患者。第二组:20 名根据 2010 年(ACR)FMS 特定标准诊断为 FMS 的患者。第三组:20 名健康成人。所有患者和对照组均接受了常规实验室检查、PTH、VD测量以及血清中铅、镉和铬水平的评估:在 RA 组和 FMS 组中,VD 与 PTH、铅、镉、铬和活动评分呈明显的反比关系。铅、镉和铬对RA患者的VD水平有明显的独立风险,而铅对FMS患者的VD水平有明显的独立风险:重金属可能会影响VD的合成,导致RA和FMS患者维生素D不足和继发性甲状旁腺功能亢进。重金属在RA和FMS的发病机制及其疾病活动中起着关键作用。
{"title":"Environmental pollution impact on the severity of some rheumatic diseases: a comparative analytical study on inflammatory and non-inflammatory samples.","authors":"Adel Elbeialy, Soaad El Sawy, Hala Elzomor, Rana Haddad","doi":"10.1186/s41927-024-00420-8","DOIUrl":"https://doi.org/10.1186/s41927-024-00420-8","url":null,"abstract":"<p><strong>Objective: </strong>Environmental pollution of heavy metals is increasingly a problem and has become of great concern due to the adverse effects it causes worldwide. Heavy metal exposure has been implicated in health problems, including fibromyalgia and rheumatoid arthritis. We aim to evaluate the rule of chronic heavy metals toxicity on the induction of vitamin D3 (VD) deficiency and parathyroid hormone (PTH) disturbances in an inflammatory disease like rheumatoid arthritis (RA) and non-inflammatory disease like fibromyalgia syndrome (FMS).</p><p><strong>Methods: </strong>This comparative analytical study was conducted on sixty adults (age ≥ 18 years). Participants were divided into three groups. Group I: twenty patients diagnosed with RA according to the specific ACR/EULAR criteria for RA. Group II: twenty patients diagnosed with FMS according to the specific 2010 (ACR) criteria for FMS. Group III: twenty healthy adults. All patients and controls were subjected to routine laboratory tests as well as the measurement of PTH, VD and estimation of serum levels of lead, cadmium, and chromium.</p><p><strong>Results: </strong>VD was significantly inversely correlated to PTH, lead, cadmium, chromium, and activity scores in the RA and FMS groups. Lead, Cadmium and Chromium had a significant independent risk on the VD level in RA patients, while lead had a significant independent risk on the VD level in FMS patients.</p><p><strong>Conclusion: </strong>Heavy metals may affect VD synthesis, leading to hypovitaminosis D and secondary hyperparathyroidism in RA and FMS patients. Heavy metals play a key role in the pathogenesis of RA, FMS, and their disease activity.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential role of fatigue in difficult-to-treat rheumatoid arthritis. 疲劳在难以治疗的类风湿关节炎中的潜在作用。
IF 2.1 Q3 RHEUMATOLOGY Pub Date : 2024-09-30 DOI: 10.1186/s41927-024-00423-5
Leticia Leon, Dalifer Freites-Núñez, Alfredo Madrid, María Rodriguez-Mariblanca, Benjamín Fernandez-Gutierrez, Lydia Abasolo

Objectives: A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple drugs are deemed to have "difficult-to-treat RA" (D2T RA). Fatigue is a burdensome symptom for RA patients, hindering their improvement. Our purpose was to evaluate the role of fatigue in D2T RA.

Methods: This cross-sectional study included rheumatoid arthritis (RA) patients between 2018 and 2022, treated with biological agents or targeted synthetic disease-modifying antirheumatic drugs. D2T RA was defined attending EULAR criteria. Independent variable was fatigue (dimensions and impact) assessed by the Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire and Numerical Rating Scales. Covariables: sociodemographic, clinical and treatment. To identify factors independently associated to D2T RA, multivariable logistic regression was run.

Results: The study included 145 patients and 38 (26.21%) developed D2T RA. D2T RA group were older, with more comorbidity and disability. D2T RA patients scored higher for global fatigue (p = 0.003), and almost for all their dimensions except for cognitive fatigue (p = 0.06) and fatigue coping (p = 0.07). Females with D2T RA showed more fatigue than those with non-D2T RA. In the adjusted models, all fatigue dimensions were associated with D2T RA: global fatigue RA (OR: 1.03; p = 0.007), physical (OR: 1.09; p = 0.008), living (OR: 1.09; p = 0.016), cognitive (OR: 1.1; p = 0.046) and emotional (OR: 1.18; p = 0.012).

Conclusions: Despite the absence of an explicit mention of fatigue in the definition of D2T RA, it appears to be associated to this outcome. Fatigue should be evaluated in a multidimensional perspective, and gender-specific differences should be considered.

目标:在类风湿性关节炎(RA)患者中,有一部分人在服用多种药物无效后仍无症状,他们被认为患有 "难治性 RA"(D2T RA)。疲劳是类风湿关节炎患者的一个沉重负担,阻碍了他们病情的改善。我们的目的是评估疲劳在 D2T RA 中的作用:这项横断面研究纳入了2018年至2022年间接受生物制剂或靶向合成改善病情抗风湿药物治疗的类风湿关节炎(RA)患者。D2T RA是根据EULAR标准定义的。自变量为疲劳(维度和影响),由布里斯托尔类风湿关节炎疲劳多维问卷和数字评分量表评估。协变量:社会人口学、临床和治疗。为确定与D2T RA独立相关的因素,进行了多变量逻辑回归:研究共纳入 145 名患者,其中 38 人(26.21%)发展为 D2T RA。D2T RA组患者年龄较大,合并症和残疾情况较多。D2T RA 患者的整体疲劳得分较高(p = 0.003),除认知疲劳(p = 0.06)和疲劳应对(p = 0.07)外,几乎所有方面的得分都较高。女性D2T RA患者比非D2T RA患者表现出更多的疲劳。在调整模型中,所有疲劳维度均与D2T RA相关:全面疲劳RA(OR:1.03;p = 0.007)、身体(OR:1.09;p = 0.008)、生活(OR:1.09;p = 0.016)、认知(OR:1.1;p = 0.046)和情绪(OR:1.18;p = 0.012):结论:尽管D2T RA的定义中没有明确提及疲劳,但疲劳似乎与这一结果有关。疲劳应从多维角度进行评估,并应考虑性别差异。
{"title":"The potential role of fatigue in difficult-to-treat rheumatoid arthritis.","authors":"Leticia Leon, Dalifer Freites-Núñez, Alfredo Madrid, María Rodriguez-Mariblanca, Benjamín Fernandez-Gutierrez, Lydia Abasolo","doi":"10.1186/s41927-024-00423-5","DOIUrl":"10.1186/s41927-024-00423-5","url":null,"abstract":"<p><strong>Objectives: </strong>A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple drugs are deemed to have \"difficult-to-treat RA\" (D2T RA). Fatigue is a burdensome symptom for RA patients, hindering their improvement. Our purpose was to evaluate the role of fatigue in D2T RA.</p><p><strong>Methods: </strong>This cross-sectional study included rheumatoid arthritis (RA) patients between 2018 and 2022, treated with biological agents or targeted synthetic disease-modifying antirheumatic drugs. D2T RA was defined attending EULAR criteria. Independent variable was fatigue (dimensions and impact) assessed by the Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire and Numerical Rating Scales. Covariables: sociodemographic, clinical and treatment. To identify factors independently associated to D2T RA, multivariable logistic regression was run.</p><p><strong>Results: </strong>The study included 145 patients and 38 (26.21%) developed D2T RA. D2T RA group were older, with more comorbidity and disability. D2T RA patients scored higher for global fatigue (p = 0.003), and almost for all their dimensions except for cognitive fatigue (p = 0.06) and fatigue coping (p = 0.07). Females with D2T RA showed more fatigue than those with non-D2T RA. In the adjusted models, all fatigue dimensions were associated with D2T RA: global fatigue RA (OR: 1.03; p = 0.007), physical (OR: 1.09; p = 0.008), living (OR: 1.09; p = 0.016), cognitive (OR: 1.1; p = 0.046) and emotional (OR: 1.18; p = 0.012).</p><p><strong>Conclusions: </strong>Despite the absence of an explicit mention of fatigue in the definition of D2T RA, it appears to be associated to this outcome. Fatigue should be evaluated in a multidimensional perspective, and gender-specific differences should be considered.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142341695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Menopausal state and rheumatoid arthritis: a systematic review and meta-analysis. 更年期状态与类风湿性关节炎:系统回顾与荟萃分析。
IF 2.1 Q3 RHEUMATOLOGY Pub Date : 2024-09-30 DOI: 10.1186/s41927-024-00418-2
Negin Namavari, Mohammad Jokar, Arnoosh Ghodsian, Hossein Kargar Jahromi, Vahid Rahmanian

Background: Rheumatoid arthritis (RA) is a chronic inflammatory condition primarily affecting the joints. The higher prevalence of RA among females, combined with the known effects of sex hormones on immune function, has led researchers to investigate the potential relationship between menopausal status and the risk, severity, or progression of RA. This systematic review and meta-analysis aimed to determine the association between menopause and rheumatoid arthritis.

Methods: In 2023, we conducted a comprehensive search across multiple databases, including Google Scholar, Scopus, PubMed/MEDLINE, Science Direct, Web of Science, EMBASE, Springer, and ProQuest. The search aimed to identify studies exploring the association between menopause and rheumatoid arthritis.

Results: Our analysis revealed that post-menopausal women had a higher risk of developing rheumatoid arthritis compared to pre-menopausal women, with an estimated odds ratio of 1.35 (95% CI: 1.04-1.67). Additionally, women who experienced early menopause (defined as onset before age 45) showed significantly higher odds of developing RA, with an odds ratio of 2.97 (95% CI: 1.73-4.22).

Conclusion: These findings highlight the importance of considering menopausal status when assessing the risk of RA development in women. The results suggest that post-menopausal women, particularly those who experience early menopause, may be at higher risk for developing RA. Further research in this area could provide valuable insights into potential preventive measures and targeted interventions for high-risk individuals.

背景:类风湿性关节炎(RA)是一种主要影响关节的慢性炎症。女性的风湿性关节炎发病率较高,加上性激素对免疫功能的已知影响,促使研究人员调查更年期状态与风湿性关节炎的风险、严重程度或进展之间的潜在关系。本系统综述和荟萃分析旨在确定更年期与类风湿关节炎之间的关系:2023 年,我们对多个数据库进行了全面检索,包括 Google Scholar、Scopus、PubMed/MEDLINE、Science Direct、Web of Science、EMBASE、Springer 和 ProQuest。搜索的目的是找出探讨更年期与类风湿性关节炎之间关系的研究:我们的分析表明,与绝经前妇女相比,绝经后妇女患类风湿性关节炎的风险更高,估计的几率比为 1.35(95% CI:1.04-1.67)。此外,更年期提前(定义为 45 岁之前发病)的女性患 RA 的几率明显更高,几率比为 2.97(95% CI:1.73-4.22):这些发现强调了在评估女性罹患 RA 的风险时考虑绝经状态的重要性。结果表明,绝经后的女性,尤其是绝经较早的女性,患 RA 的风险可能较高。在这一领域的进一步研究可为潜在的预防措施和针对高危人群的干预措施提供有价值的见解。
{"title":"Menopausal state and rheumatoid arthritis: a systematic review and meta-analysis.","authors":"Negin Namavari, Mohammad Jokar, Arnoosh Ghodsian, Hossein Kargar Jahromi, Vahid Rahmanian","doi":"10.1186/s41927-024-00418-2","DOIUrl":"10.1186/s41927-024-00418-2","url":null,"abstract":"<p><strong>Background: </strong>Rheumatoid arthritis (RA) is a chronic inflammatory condition primarily affecting the joints. The higher prevalence of RA among females, combined with the known effects of sex hormones on immune function, has led researchers to investigate the potential relationship between menopausal status and the risk, severity, or progression of RA. This systematic review and meta-analysis aimed to determine the association between menopause and rheumatoid arthritis.</p><p><strong>Methods: </strong>In 2023, we conducted a comprehensive search across multiple databases, including Google Scholar, Scopus, PubMed/MEDLINE, Science Direct, Web of Science, EMBASE, Springer, and ProQuest. The search aimed to identify studies exploring the association between menopause and rheumatoid arthritis.</p><p><strong>Results: </strong>Our analysis revealed that post-menopausal women had a higher risk of developing rheumatoid arthritis compared to pre-menopausal women, with an estimated odds ratio of 1.35 (95% CI: 1.04-1.67). Additionally, women who experienced early menopause (defined as onset before age 45) showed significantly higher odds of developing RA, with an odds ratio of 2.97 (95% CI: 1.73-4.22).</p><p><strong>Conclusion: </strong>These findings highlight the importance of considering menopausal status when assessing the risk of RA development in women. The results suggest that post-menopausal women, particularly those who experience early menopause, may be at higher risk for developing RA. Further research in this area could provide valuable insights into potential preventive measures and targeted interventions for high-risk individuals.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11441135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142341694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data. 依那西普和英夫利昔单抗启动者的严重感染发生率:生物仿制药和生物原研药与加拿大人群数据的安全性比较。
IF 2.1 Q3 RHEUMATOLOGY Pub Date : 2024-09-27 DOI: 10.1186/s41927-024-00415-5
Marina G Birck, Luck Lukusa, Denis Choquette, Gilles Boire, Walter P Maksymowych, Harminder Singh, Waqqas Afif, Sasha Bernatsky

Background: Safety remains a significant concern for biologic drugs, and studies are needed to ensure a comparable safety profile for biosimilars and their legacy treatments. Using Canadian administrative health data from 2015-2019, we compared the incidence of serious infection between biosimilars and bio-originators initiators for etanercept and infliximab, two of the most commonly used biologics during this time.

Methods: We performed a retrospective cohort study using pan-Canadian data (except Quebec) from the National Prescription Drug Utilization Information System linked to hospitalization data. We studied new users of infliximab or etanercept (January/2015-December/2019) and compared incidence rates of serious infection, defined as those which required hospitalization, by using Cox regression models adjusted by biological sex, age at treatment initiation, prior corticosteroid or biologic, province, and calendar year.

Results: We studied 6,583 etanercept users (mean age 62) and 7,202 infliximab users (mean age 45). Hospitalization with infections occurred in 7% of infliximab and 2% of etanercept users. Comparing the risk of infection between biosimilar to bio-originator, the adjusted hazard ratio (95% confidence interval) was 1.33 (0.77, 2.30) for etanercept and 0.93 (0.72, 1.18) for infliximab.

Conclusions: Our study found no clear difference between etanercept and infliximab biosimilars and their bio-originators for infection incidence, suggesting a similar safety profile.

背景:安全性仍然是生物制药的一个重大问题,需要进行研究以确保生物仿制药及其传统疗法具有可比的安全性。我们利用 2015-2019 年的加拿大行政健康数据,比较了生物仿制药和生物原研药启动者在依那西普(etanercept)和英夫利昔单抗(infliximab)严重感染的发生率,依那西普和英夫利昔单抗是这一时期最常用的两种生物制剂:我们使用国家处方药使用信息系统(National Prescription Drug Utilization Information System)中与住院数据相关联的泛加拿大(魁北克除外)数据进行了一项回顾性队列研究。我们研究了英夫利昔单抗或依那西普(etanercept)的新用户(2015 年 1 月至 2019 年 12 月),并比较了严重感染(定义为需要住院治疗的感染)的发生率,采用 Cox 回归模型,根据生物性别、开始治疗时的年龄、之前使用的皮质类固醇或生物制剂、省份和日历年进行调整:我们对 6583 名依那西普使用者(平均年龄 62 岁)和 7202 名英夫利西单抗使用者(平均年龄 45 岁)进行了研究。因感染住院的英夫利昔单抗使用者占 7%,依那西普使用者占 2%。比较生物仿制药和生物原研药的感染风险,依那西普的调整后危险比(95% 置信区间)为 1.33(0.77, 2.30),英夫利西单抗为 0.93(0.72, 1.18):我们的研究发现,依那西普和英夫利昔单抗生物仿制药与其生物原研药在感染发生率方面没有明显差异,这表明它们具有相似的安全性。
{"title":"Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data.","authors":"Marina G Birck, Luck Lukusa, Denis Choquette, Gilles Boire, Walter P Maksymowych, Harminder Singh, Waqqas Afif, Sasha Bernatsky","doi":"10.1186/s41927-024-00415-5","DOIUrl":"10.1186/s41927-024-00415-5","url":null,"abstract":"<p><strong>Background: </strong>Safety remains a significant concern for biologic drugs, and studies are needed to ensure a comparable safety profile for biosimilars and their legacy treatments. Using Canadian administrative health data from 2015-2019, we compared the incidence of serious infection between biosimilars and bio-originators initiators for etanercept and infliximab, two of the most commonly used biologics during this time.</p><p><strong>Methods: </strong>We performed a retrospective cohort study using pan-Canadian data (except Quebec) from the National Prescription Drug Utilization Information System linked to hospitalization data. We studied new users of infliximab or etanercept (January/2015-December/2019) and compared incidence rates of serious infection, defined as those which required hospitalization, by using Cox regression models adjusted by biological sex, age at treatment initiation, prior corticosteroid or biologic, province, and calendar year.</p><p><strong>Results: </strong>We studied 6,583 etanercept users (mean age 62) and 7,202 infliximab users (mean age 45). Hospitalization with infections occurred in 7% of infliximab and 2% of etanercept users. Comparing the risk of infection between biosimilar to bio-originator, the adjusted hazard ratio (95% confidence interval) was 1.33 (0.77, 2.30) for etanercept and 0.93 (0.72, 1.18) for infliximab.</p><p><strong>Conclusions: </strong>Our study found no clear difference between etanercept and infliximab biosimilars and their bio-originators for infection incidence, suggesting a similar safety profile.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11441163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142341693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Socioeconomic status, reserve capacity, and depressive symptoms predict pain in Rheumatoid Arthritis: an examination of the reserve capacity model. 社会经济地位、储备能力和抑郁症状可预测类风湿关节炎患者的疼痛:对储备能力模型的研究。
IF 2.1 Q3 RHEUMATOLOGY Pub Date : 2024-09-20 DOI: 10.1186/s41927-024-00416-4
Desiree R Azizoddin, Richard Olmstead, Kris-Ann Anderson, Alanna E Hirz, Michael R Irwin, Shadi Gholizadeh, Michael Weisman, Mariko Ishimori, Daniel Wallace, Perry Nicassio

Background: Guided by the reserve capacity model, we evaluated the unique relationships between socioeconomic status (SES), reserve capacity (helplessness, self-efficacy, social support), and negative emotions on pain in patients with Rheumatoid Arthritis (RA).

Methods: The secondary analysis used baseline, cross-sectional data from 106 adults in a clinical trial comparing behavioral treatments for RA. Patients were eligible if they were ≥ 18 years old, met the ACR criteria for RA (determined by study rheumatologist), had stable disease and drug regimens for 3 months, and did not have a significant comorbid condition. Structural equation modeling evaluated the direct effects of SES, reserve capacity (helplessness- Arthritis Helplessness Index, self-efficacy -Personal Mastery Scale, social support- Social Provisions Scale) and negative emotions (stress and depressive symptoms- Perceived Stress Scale and Hamilton Depression Rating Scale) on pain (Rapid Assessment of Disease Activity in Rheumatology-RADAR & visual analog scale-VAS), and the indirect effects of SES as mediated by reserve capacity and negative emotions. The SEM model was evaluated using multiple fit criteria: χ2 goodness-of-fit statistic, the comparative fit index (CFI), the standardized root mean square residual (SRMR), and the root mean square error of approximation (RMSEA).

Results: Participants were mostly female (85%), 55.45 years old on average, self-identified as white (61%), Hispanic (16%), black (13%), and other (10%), and had RA for an average of 10.63 years. Results showed that low SES contributed to worse pain, through lower reserve capacity and higher negative emotions. Mediational analyses showed that reserve capacity and negative emotions partially mediated the effect of SES on pain. The final model explained 39% of the variance in pain.

Conclusions: The findings indicate that lower SES was related to worse clinical pain outcomes and negative emotions and reserve capacity (helplessness, social support, and self-efficacy) mediated the effect of SES on pain. A primary limitation is the small sample size; future studies should evaluate this model further in larger, longitudinal approaches. Interventions that target negative emotions in patients with low SES may facilitate better pain control with RA.

Trial registration: clinicaltrials.gov NCT00072657 01/02/2004 20/03/2009.

背景:在储备能力模型的指导下,我们评估了类风湿关节炎(RA)患者的社会经济地位(SES)、储备能力(无助感、自我效能感、社会支持)和负面情绪对疼痛的独特影响:二次分析使用了一项比较类风湿性关节炎行为疗法的临床试验中 106 名成人的基线横截面数据。患者年龄≥18岁,符合ACR的RA标准(由研究中的风湿病学家确定),病情和用药方案稳定3个月,且无严重并发症,即符合条件。结构方程模型评估了社会经济地位、储备能力(无助感-关节炎无助感指数、自我效能-个人掌握量表、社会支持-社会供给量表)和负面情绪(压力和抑郁症状-感知压力量表和汉密尔顿抑郁评分量表)对疼痛(风湿病学疾病活动性快速评估-RADAR和视觉模拟量表-VAS)的直接影响,以及社会经济地位在储备能力和负面情绪中介下的间接影响。采用多种拟合标准对 SEM 模型进行了评估:χ2 拟合度统计量、比较拟合指数(CFI)、标准化均方根残差(SRMR)和均方根近似误差(RMSEA):参与者大多为女性(85%),平均年龄 55.45 岁,自我认同为白人(61%)、西班牙裔(16%)、黑人(13%)和其他(10%),平均患有 RA 10.63 年。研究结果表明,低社会经济地位通过较低的储备能力和较高的负面情绪导致疼痛加剧。中介分析表明,储备能力和消极情绪部分中介了社会经济地位对疼痛的影响。最终模型解释了39%的疼痛变异:研究结果表明,较低的社会经济地位与较差的临床疼痛结果有关,而消极情绪和储备能力(无助感、社会支持和自我效能感)是社会经济地位对疼痛影响的中介。该研究的主要局限性在于样本量较小;未来的研究应采用更大规模的纵向方法来进一步评估该模型。针对低社会经济地位患者负面情绪的干预措施可能有助于更好地控制RA疼痛。试验注册:clinicaltrials.gov NCT00072657 01/02/2004 20/03/2009。
{"title":"Socioeconomic status, reserve capacity, and depressive symptoms predict pain in Rheumatoid Arthritis: an examination of the reserve capacity model.","authors":"Desiree R Azizoddin, Richard Olmstead, Kris-Ann Anderson, Alanna E Hirz, Michael R Irwin, Shadi Gholizadeh, Michael Weisman, Mariko Ishimori, Daniel Wallace, Perry Nicassio","doi":"10.1186/s41927-024-00416-4","DOIUrl":"10.1186/s41927-024-00416-4","url":null,"abstract":"<p><strong>Background: </strong>Guided by the reserve capacity model, we evaluated the unique relationships between socioeconomic status (SES), reserve capacity (helplessness, self-efficacy, social support), and negative emotions on pain in patients with Rheumatoid Arthritis (RA).</p><p><strong>Methods: </strong>The secondary analysis used baseline, cross-sectional data from 106 adults in a clinical trial comparing behavioral treatments for RA. Patients were eligible if they were ≥ 18 years old, met the ACR criteria for RA (determined by study rheumatologist), had stable disease and drug regimens for 3 months, and did not have a significant comorbid condition. Structural equation modeling evaluated the direct effects of SES, reserve capacity (helplessness- Arthritis Helplessness Index, self-efficacy -Personal Mastery Scale, social support- Social Provisions Scale) and negative emotions (stress and depressive symptoms- Perceived Stress Scale and Hamilton Depression Rating Scale) on pain (Rapid Assessment of Disease Activity in Rheumatology-RADAR & visual analog scale-VAS), and the indirect effects of SES as mediated by reserve capacity and negative emotions. The SEM model was evaluated using multiple fit criteria: χ<sup>2</sup> goodness-of-fit statistic, the comparative fit index (CFI), the standardized root mean square residual (SRMR), and the root mean square error of approximation (RMSEA).</p><p><strong>Results: </strong>Participants were mostly female (85%), 55.45 years old on average, self-identified as white (61%), Hispanic (16%), black (13%), and other (10%), and had RA for an average of 10.63 years. Results showed that low SES contributed to worse pain, through lower reserve capacity and higher negative emotions. Mediational analyses showed that reserve capacity and negative emotions partially mediated the effect of SES on pain. The final model explained 39% of the variance in pain.</p><p><strong>Conclusions: </strong>The findings indicate that lower SES was related to worse clinical pain outcomes and negative emotions and reserve capacity (helplessness, social support, and self-efficacy) mediated the effect of SES on pain. A primary limitation is the small sample size; future studies should evaluate this model further in larger, longitudinal approaches. Interventions that target negative emotions in patients with low SES may facilitate better pain control with RA.</p><p><strong>Trial registration: </strong>clinicaltrials.gov NCT00072657 01/02/2004 20/03/2009.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A higher body mass index and increased syndesmophytes volume are associated with facet joints ankylosis on thoracic spine in patients with ankylosing spondylitis: a retrospective cohort study 强直性脊柱炎患者胸椎面关节强直与体重指数升高和联合韧带体积增大有关:一项回顾性队列研究
IF 2.2 Q3 RHEUMATOLOGY Pub Date : 2024-09-18 DOI: 10.1186/s41927-024-00408-4
Simin Liao, Jian Shang, Liuquan Cheng, Jian Zhu, Feng Huang
To investigate the association between syndesmophytes and facet joint (FJ) lesions in patients with ankylosing spondylitis (AS), and to identify clinical factors associated with FJ ankylosis (FJA) in thoracic segment. Ninety-seven patients with AS who underwent thoracic spine computed tomography (CT) or chest CT and without completely thoracic spine fusion were included. FJ lesions were analyzed for the numbers and distribution of normal, ankylosis, erosions, joint-space narrowing, osteophytes, and subchondral sclerosis. The volume of vertebral syndesmophtes unit (VSU) and total thoracic syndesmophtes volume were separately calculated by Mimics software. Clinical factors associated with FJA were investigated using generalized estimation equation (GEE). The association between syndesmophtes volume and numbers of FJ structural lesions was analyzed using generalized additive mixed model (GAMM). 2328 FJ and 1164 VSUs in thoracic spine were assessed. The majority FJ structural lesions were ankylosis (32.39%). FJA was more frequently seen in vertebrae with syndesmophytes formation (p < 0.001). GEE showed that patients with normal BMI (18.5–24.9 kg/m2) and high BMI (> 24.9 kg/m2) were more likely to have FJA in thoracic spine (odds rations [95% confidence interval]: 0.27(0.12–0.59), 1.45(1.03–8.57), respectively). GAMM showed that syndesmophytes volume increase the numbers of FJA (standard β = 0.009, p < 0.05) and decreased the numbers of normal FJ (standard β = -0.07, p < 0.01). FJA was the most common FJ structural lesion in thoracic spine, and it increases linearly with syndesmophytes before the bridging syndesmophytes formed. A higher BMI (especially > 24.9 kg/m2) and increased syndesmophytes volume are associated with FJA in thoracic spine.
目的:研究强直性脊柱炎(AS)患者的联合骨赘与面关节(FJ)病变之间的关联,并确定与胸椎面关节强直(FJA)相关的临床因素。研究纳入了97名接受过胸椎计算机断层扫描(CT)或胸部CT检查且未进行完全胸椎融合术的强直性脊柱炎患者。对FJ病变的数量和分布进行了分析,包括正常、强直、侵蚀、关节间隙狭窄、骨质增生和软骨下硬化。用 Mimics 软件分别计算了椎体联合单位(VSU)的体积和胸椎联合总体积。使用广义估计方程(GEE)研究了与 FJA 相关的临床因素。采用广义相加混合模型(GAMM)分析了胸廓联合容积与 FJ 结构性病变数量之间的关系。对胸椎的 2328 个 FJ 和 1164 个 VSU 进行了评估。大多数 FJ 结构性病变为强直(32.39%)。FJA更多见于有联合骨赘形成的椎体(P 24.9 kg/m2),胸椎更有可能出现FJA(几率[95%置信区间]:0.27(0.12-0.8 kg/m2)):分别为 0.27(0.12-0.59)、1.45(1.03-8.57))。GAMM显示,椎体联合体积会增加FJA的数量(标准β=0.009,P 24.9 kg/m2),椎体联合体积的增加与胸椎的FJA有关。
{"title":"A higher body mass index and increased syndesmophytes volume are associated with facet joints ankylosis on thoracic spine in patients with ankylosing spondylitis: a retrospective cohort study","authors":"Simin Liao, Jian Shang, Liuquan Cheng, Jian Zhu, Feng Huang","doi":"10.1186/s41927-024-00408-4","DOIUrl":"https://doi.org/10.1186/s41927-024-00408-4","url":null,"abstract":"To investigate the association between syndesmophytes and facet joint (FJ) lesions in patients with ankylosing spondylitis (AS), and to identify clinical factors associated with FJ ankylosis (FJA) in thoracic segment. Ninety-seven patients with AS who underwent thoracic spine computed tomography (CT) or chest CT and without completely thoracic spine fusion were included. FJ lesions were analyzed for the numbers and distribution of normal, ankylosis, erosions, joint-space narrowing, osteophytes, and subchondral sclerosis. The volume of vertebral syndesmophtes unit (VSU) and total thoracic syndesmophtes volume were separately calculated by Mimics software. Clinical factors associated with FJA were investigated using generalized estimation equation (GEE). The association between syndesmophtes volume and numbers of FJ structural lesions was analyzed using generalized additive mixed model (GAMM). 2328 FJ and 1164 VSUs in thoracic spine were assessed. The majority FJ structural lesions were ankylosis (32.39%). FJA was more frequently seen in vertebrae with syndesmophytes formation (p < 0.001). GEE showed that patients with normal BMI (18.5–24.9 kg/m2) and high BMI (> 24.9 kg/m2) were more likely to have FJA in thoracic spine (odds rations [95% confidence interval]: 0.27(0.12–0.59), 1.45(1.03–8.57), respectively). GAMM showed that syndesmophytes volume increase the numbers of FJA (standard β = 0.009, p < 0.05) and decreased the numbers of normal FJ (standard β = -0.07, p < 0.01). FJA was the most common FJ structural lesion in thoracic spine, and it increases linearly with syndesmophytes before the bridging syndesmophytes formed. A higher BMI (especially > 24.9 kg/m2) and increased syndesmophytes volume are associated with FJA in thoracic spine.","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142255390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beliefs of Moroccan patients with chronic inflammatory rheumatic diseases regarding medication: related factors and correlation with therapeutic adherence 摩洛哥慢性炎症性风湿病患者的用药观念:相关因素及与坚持治疗的关系
IF 2.2 Q3 RHEUMATOLOGY Pub Date : 2024-09-18 DOI: 10.1186/s41927-024-00419-1
Fatima Zahrae Taik, Noema El Mansouri, Rajaa Bensaid, Anass Adnine, Amine Amar, Maryam Fourtassi, Fatima Ezzahra Abourazzak
Medication adherence is one of the key elements of the management of patients with chronic inflammatory rheumatic diseases (CIRDs), adherence/medication regimes are prone to being influenced by beliefs about medicines; such beliefs can influence the management and quality of life of patients. Several factors may be associated with these beliefs, including demographic and clinical factors, as well as socio-psychological factors. The aim of this study is to assess beliefs regarding medications among Moroccan patients with CIRDs, the factors associated with these beliefs, and the correlation of these factors with medication adherence. This cross-sectional study included patients with CIRDs. Sociodemographic data, comorbidities, and information about CIRDs (type, disease duration, pain evaluation, disease activity and treatments) were collected. Beliefs regarding medication were assessed by the Belief about Medicine Questionnaire (BMQ). Therapeutic adherence was assessed using the Arabic version of the Compliance Questionnaire in Rheumatology (CQR). Sociopsychological factors, such as catastrophism and trust in physicians, were assessed by the Pain Catastrophizing Scale (PCS) and the Trust in Physicians Scale (TPS), respectively. Our sample included 189 patients. The average age was 47.49 ± 13.7; 52.4% had comorbidities; and 49.2% had a low level of education. Of the patients, 49.7% were on glucocorticoids, 61.9% on conventional synthetic disease-modifying antirheumatic drugs and 6.3% on biologics. The median necessity-concern differential was 6 [1–12]. Of the patients, 67.4% strongly believed that medication was essential to maintain their health. The long-term side effects were the main concerns about medicines (51.3%). In a multivariate analysis, there was a statistically significant association between low level of education, catastrophizing, methotrexate use, and trust in the physician as independent factors and the BMQ necessity-concern differential as the dependent factor. There was also a significant correlation between CQR and the BMQ necessity score. Moroccan patients with CIRDs have a rather positive perception of their medication. This perception seems to influence their adherence to treatment. Low levels of education, catastrophizing, methotrexate use, and trust in physicians are the most important factors associated with patients’ beliefs regarding medication.
坚持用药是慢性炎症性风湿病(CIRDs)患者管理的关键要素之一,坚持用药/用药方案很容易受到药物信仰的影响;这种信仰会影响患者的管理和生活质量。这些信念可能与多种因素有关,包括人口统计和临床因素以及社会心理因素。本研究旨在评估摩洛哥 CIRD 患者的用药信念、与这些信念相关的因素以及这些因素与坚持用药的相关性。这项横断面研究包括 CIRD 患者。研究人员收集了社会人口学数据、合并症和有关 CIRD 的信息(类型、病程、疼痛评估、疾病活动和治疗方法)。对药物治疗的信念通过 "医学信念问卷"(BMQ)进行评估。治疗依从性采用阿拉伯语版风湿病学依从性问卷(CQR)进行评估。疼痛灾难化量表(PCS)和医生信任量表(TPS)分别评估了灾难化和医生信任等社会心理因素。我们的样本包括 189 名患者。平均年龄为(47.49±13.7)岁;52.4%的患者患有合并症;49.2%的患者受教育程度较低。患者中,49.7%服用糖皮质激素,61.9%服用常规合成的改善病情抗风湿药物,6.3%服用生物制剂。必要性-关注度差异的中位数为 6 [1-12]。67.4%的患者坚信药物治疗对维持他们的健康至关重要。长期副作用是患者对药物的主要担忧(51.3%)。在多变量分析中,教育程度低、灾难化、使用甲氨蝶呤和对医生的信任作为独立因素与 BMQ 必要性-担忧差异作为因果因素之间存在统计学意义上的显著关联。CQR 与 BMQ 必要性评分之间也存在明显的相关性。摩洛哥的 CIRD 患者对自己的用药有相当积极的看法。这种看法似乎影响了他们对治疗的依从性。教育水平低、灾难化、甲氨蝶呤的使用以及对医生的信任是与患者用药观念相关的最重要因素。
{"title":"Beliefs of Moroccan patients with chronic inflammatory rheumatic diseases regarding medication: related factors and correlation with therapeutic adherence","authors":"Fatima Zahrae Taik, Noema El Mansouri, Rajaa Bensaid, Anass Adnine, Amine Amar, Maryam Fourtassi, Fatima Ezzahra Abourazzak","doi":"10.1186/s41927-024-00419-1","DOIUrl":"https://doi.org/10.1186/s41927-024-00419-1","url":null,"abstract":"Medication adherence is one of the key elements of the management of patients with chronic inflammatory rheumatic diseases (CIRDs), adherence/medication regimes are prone to being influenced by beliefs about medicines; such beliefs can influence the management and quality of life of patients. Several factors may be associated with these beliefs, including demographic and clinical factors, as well as socio-psychological factors. The aim of this study is to assess beliefs regarding medications among Moroccan patients with CIRDs, the factors associated with these beliefs, and the correlation of these factors with medication adherence. This cross-sectional study included patients with CIRDs. Sociodemographic data, comorbidities, and information about CIRDs (type, disease duration, pain evaluation, disease activity and treatments) were collected. Beliefs regarding medication were assessed by the Belief about Medicine Questionnaire (BMQ). Therapeutic adherence was assessed using the Arabic version of the Compliance Questionnaire in Rheumatology (CQR). Sociopsychological factors, such as catastrophism and trust in physicians, were assessed by the Pain Catastrophizing Scale (PCS) and the Trust in Physicians Scale (TPS), respectively. Our sample included 189 patients. The average age was 47.49 ± 13.7; 52.4% had comorbidities; and 49.2% had a low level of education. Of the patients, 49.7% were on glucocorticoids, 61.9% on conventional synthetic disease-modifying antirheumatic drugs and 6.3% on biologics. The median necessity-concern differential was 6 [1–12]. Of the patients, 67.4% strongly believed that medication was essential to maintain their health. The long-term side effects were the main concerns about medicines (51.3%). In a multivariate analysis, there was a statistically significant association between low level of education, catastrophizing, methotrexate use, and trust in the physician as independent factors and the BMQ necessity-concern differential as the dependent factor. There was also a significant correlation between CQR and the BMQ necessity score. Moroccan patients with CIRDs have a rather positive perception of their medication. This perception seems to influence their adherence to treatment. Low levels of education, catastrophizing, methotrexate use, and trust in physicians are the most important factors associated with patients’ beliefs regarding medication.","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142255389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crystal-induced arthritis in prosthetic joints: a systematic review of clinical features, diagnosis, management, and outcomes 晶体诱发的假关节炎:临床特征、诊断、管理和结果的系统回顾
IF 2.2 Q3 RHEUMATOLOGY Pub Date : 2024-09-14 DOI: 10.1186/s41927-024-00411-9
Haruki Sawada, Jared Dang, Bibek Saha, Luke Taylor, Yoshito Nishimura, Melissa Kahili-Heede, Cass Nakasone, Sian Yik Lim
To summarize clinical presentations, baseline characteristics, diagnosis, treatment, and treatment outcomes through a systematic review of cases of crystal-induced arthritis in prosthetic joints in the literature. A systematic review of case reports and case series was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed through PubMed/MEDLINE, Google Scholar, Embase, Cumulative Index to Nursing & Allied Health, and Web of Science. We identified case reports/case series in English of adult patients presenting with crystal-induced arthritis (gout, calcium pyrophosphate deposition disease) in prosthetic joints. Articles that met the inclusion criteria were utilized for qualitative data synthesis. We found 44 cases of crystal-induced arthritis in prosthetic joints from 1984 to 2021. Crystal-induced arthritis in periprosthetic joints most frequently affects patients who had knee arthroplasty and most often presents as monoarticular arthritis that is usually acute in onset. However, several cases in the literature involved patients who had bilateral knee replacements and presented with a concurrent flare of gout or calcium pyrophosphate deposition disease in bilateral knees. Patients with crystal-induced arthritis in prosthetic joints show elevated white blood cell counts with neutrophil predominance and respond favorably to anti-inflammatory treatments, usually within one week. In many cases, crystal-induced arthritis was challenging to differentiate from prosthetic joint infection, with approximately one-third of patients undergoing surgical intervention and 35% receiving antibiotic treatment. Crystal-induced arthritis in prosthetic joints can mimic prosthetic joint infections and should always be considered in the differential diagnoses of joint pain in prosthetic joints. We present the first systematic review of crystal-induced arthritis in prosthetic joints to increase awareness of the diagnosis and proper management.
通过对文献中人工关节晶体诱发关节炎病例的系统性回顾,总结临床表现、基线特征、诊断、治疗和治疗结果。根据《系统综述和元分析首选报告项目》(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)指南,对病例报告和系列病例进行了系统综述。我们通过 PubMed/MEDLINE、Google Scholar、Embase、Cumulative Index to Nursing & Allied Health 和 Web of Science 进行了文献检索。我们发现了一些英文病例报告/系列病例,这些病例涉及假体关节中晶体诱发的关节炎(痛风、焦磷酸钙沉积症)的成年患者。符合纳入标准的文章将用于定性数据综合。我们在 1984 年至 2021 年期间发现了 44 例人工关节晶体诱导性关节炎病例。晶体诱导的假体周围关节炎最常见于接受过膝关节置换术的患者,通常表现为急性发作的单关节炎。不过,文献中也有一些病例涉及接受双侧膝关节置换术的患者,他们同时出现痛风或双侧膝关节焦磷酸钙沉积症。晶体诱发的假关节炎患者的白细胞计数升高,以中性粒细胞为主,对抗炎药物的反应良好,通常在一周内就能治愈。在许多病例中,晶体诱导的关节炎很难与假体关节感染区分开来,约有三分之一的患者接受了手术治疗,35%的患者接受了抗生素治疗。人工关节晶体诱导性关节炎可模拟人工关节感染,在人工关节疼痛的鉴别诊断中应始终予以考虑。我们首次对晶体诱导的人工关节关节炎进行了系统回顾,以提高对该病的诊断和正确处理的认识。
{"title":"Crystal-induced arthritis in prosthetic joints: a systematic review of clinical features, diagnosis, management, and outcomes","authors":"Haruki Sawada, Jared Dang, Bibek Saha, Luke Taylor, Yoshito Nishimura, Melissa Kahili-Heede, Cass Nakasone, Sian Yik Lim","doi":"10.1186/s41927-024-00411-9","DOIUrl":"https://doi.org/10.1186/s41927-024-00411-9","url":null,"abstract":"To summarize clinical presentations, baseline characteristics, diagnosis, treatment, and treatment outcomes through a systematic review of cases of crystal-induced arthritis in prosthetic joints in the literature. A systematic review of case reports and case series was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed through PubMed/MEDLINE, Google Scholar, Embase, Cumulative Index to Nursing & Allied Health, and Web of Science. We identified case reports/case series in English of adult patients presenting with crystal-induced arthritis (gout, calcium pyrophosphate deposition disease) in prosthetic joints. Articles that met the inclusion criteria were utilized for qualitative data synthesis. We found 44 cases of crystal-induced arthritis in prosthetic joints from 1984 to 2021. Crystal-induced arthritis in periprosthetic joints most frequently affects patients who had knee arthroplasty and most often presents as monoarticular arthritis that is usually acute in onset. However, several cases in the literature involved patients who had bilateral knee replacements and presented with a concurrent flare of gout or calcium pyrophosphate deposition disease in bilateral knees. Patients with crystal-induced arthritis in prosthetic joints show elevated white blood cell counts with neutrophil predominance and respond favorably to anti-inflammatory treatments, usually within one week. In many cases, crystal-induced arthritis was challenging to differentiate from prosthetic joint infection, with approximately one-third of patients undergoing surgical intervention and 35% receiving antibiotic treatment. Crystal-induced arthritis in prosthetic joints can mimic prosthetic joint infections and should always be considered in the differential diagnoses of joint pain in prosthetic joints. We present the first systematic review of crystal-induced arthritis in prosthetic joints to increase awareness of the diagnosis and proper management.","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142255392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors of methotrexate monotherapy success in patients with rheumatoid arthritis in a national referral center: a cohort study 国家转诊中心类风湿关节炎患者甲氨蝶呤单药治疗成功的预测因素:一项队列研究
IF 2.2 Q3 RHEUMATOLOGY Pub Date : 2024-09-12 DOI: 10.1186/s41927-024-00412-8
Rudy Hidayat, Fara Fauzia, Faisal Parlindungan, Suryo Anggoro Kusumo Wibowo, Anna Ariane, Johanda Damanik, Abirianty Priandani Araminta
Methotrexate (MTX) remains the recommended first-line treatment for rheumatoid arthritis (RA); however, its response varies and is influenced by various factors. This study aimed to identify predictors of MTX monotherapy treatment success in an Indonesian cohort. This retrospective cohort study included newly diagnosed RA patients receiving MTX monotherapy. Treatment success was defined as achieving remission or low disease activity according to Disease Activity Score-28 with erythrocyte sedimentation rate (DAS28-ESR) after 12 months of MTX therapy. The association between demographic, clinical, and laboratory factors and achieving therapy targets was evaluated using multivariate logistic regression analysis. Among 254 subjects, 59.4% achieved treatment success with MTX monotherapy, with remission attained in 33% and low disease activity in 26.4%. Most subjects were female (95.7%) with a mean age of 48 ± 11 years. Multivariate analysis revealed that lower disease activity (OR 1.97; 95% CI [1.04–3.72]), normal ESR (OR 2.58; 95% CI [1.05–6.34]), normoweight (OR 2.55, 95% CI [1.45–4.49]), and tender joint count ≤ 5 (OR 2.45, 95% CI [1.31–4.58]) were significant predictors of treatment success. The rate of MTX monotherapy success in our study was 59.4%. Lower disease activity, normal ESR, normoweight, and fewer tender joints at baseline were significant predictors of treatment success.
甲氨蝶呤(MTX)仍是治疗类风湿性关节炎(RA)的推荐一线疗法;然而,该疗法的反应各不相同,并受到各种因素的影响。本研究旨在确定印度尼西亚队列中MTX单药治疗成功的预测因素。这项回顾性队列研究纳入了接受MTX单药治疗的新确诊的RA患者。治疗成功的定义是,在接受MTX治疗12个月后,根据疾病活动度评分-28和红细胞沉降率(DAS28-ESR),疾病活动度达到缓解或较低。采用多变量逻辑回归分析评估了人口统计学、临床和实验室因素与达到治疗目标之间的关系。在254名受试者中,59.4%的受试者在接受MTX单药治疗后取得了成功,33%的受试者病情得到缓解,26.4%的受试者病情活动性较低。大多数受试者为女性(95.7%),平均年龄为(48 ± 11)岁。多变量分析显示,较低的疾病活动度(OR 1.97;95% CI [1.04-3.72])、正常的血沉(OR 2.58;95% CI [1.05-6.34])、正常的体重(OR 2.55,95% CI [1.45-4.49])和关节触痛数≤5(OR 2.45,95% CI [1.31-4.58])是治疗成功的重要预测因素。在我们的研究中,MTX单药治疗的成功率为59.4%。较低的疾病活动度、正常的血沉、正常的体重和基线时较少的关节压痛是治疗成功的重要预测因素。
{"title":"Predictive factors of methotrexate monotherapy success in patients with rheumatoid arthritis in a national referral center: a cohort study","authors":"Rudy Hidayat, Fara Fauzia, Faisal Parlindungan, Suryo Anggoro Kusumo Wibowo, Anna Ariane, Johanda Damanik, Abirianty Priandani Araminta","doi":"10.1186/s41927-024-00412-8","DOIUrl":"https://doi.org/10.1186/s41927-024-00412-8","url":null,"abstract":"Methotrexate (MTX) remains the recommended first-line treatment for rheumatoid arthritis (RA); however, its response varies and is influenced by various factors. This study aimed to identify predictors of MTX monotherapy treatment success in an Indonesian cohort. This retrospective cohort study included newly diagnosed RA patients receiving MTX monotherapy. Treatment success was defined as achieving remission or low disease activity according to Disease Activity Score-28 with erythrocyte sedimentation rate (DAS28-ESR) after 12 months of MTX therapy. The association between demographic, clinical, and laboratory factors and achieving therapy targets was evaluated using multivariate logistic regression analysis. Among 254 subjects, 59.4% achieved treatment success with MTX monotherapy, with remission attained in 33% and low disease activity in 26.4%. Most subjects were female (95.7%) with a mean age of 48 ± 11 years. Multivariate analysis revealed that lower disease activity (OR 1.97; 95% CI [1.04–3.72]), normal ESR (OR 2.58; 95% CI [1.05–6.34]), normoweight (OR 2.55, 95% CI [1.45–4.49]), and tender joint count ≤ 5 (OR 2.45, 95% CI [1.31–4.58]) were significant predictors of treatment success. The rate of MTX monotherapy success in our study was 59.4%. Lower disease activity, normal ESR, normoweight, and fewer tender joints at baseline were significant predictors of treatment success.","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 托法替尼对类风湿关节炎患者骨转换标志物和骨调节剂的影响
IF 2.2 Q3 RHEUMATOLOGY Pub Date : 2024-09-10 DOI: 10.1186/s41927-024-00414-6
Giovanni Adami, Giovanni Orsolini, Maurizio Rossini, Anna Fratucello, Angelo Fassio, Ombretta Viapiana, Elena Fracassi, Riccardo Bixio, Davide Gatti
Bone turnover makers (P1nP, B-ALP, CTX), bone modulators (Dkk1, sclerostin) and BMD were measured prospectively in rheumatoid arthritis patients treated with tofacitinib. Sclerostin increased significantly after treatment with tofacitinib, P1nP and B-ALP (markers of bone formation) decreased significantly. Rheumatoid arthritis (RA) is characterized by bone loss. It is unclear whether JAK inhibitors can attenuate bone loss in RA by modulating bone metabolism. The main objective of our study is to investigate the effects of tofacitinib on serum levels of bone turnover markers and modulators. Secondary objectives were to assess changes in bone mineral density (BMD), metacarpal index, bone erosions. We conducted a prospective observational study on patients with active RA failure to bDMARDs or tsDMARDs initiating treatment with tofacitinib. We measured at baseline and after 1, 2, 3, 6, 9 and 12 months: serum bone turnover markers (CTX, P1nP, B-ALP), bone modulators (Dkk-1, sclerostin, vitamin D, PTH, OPG and RANKL), BMD and radiographic parameters (Sharp van der Heijde score [SvdH], bone health index [BHI] and metacarpal index [MCI]). 30 patients were enrolled in the study of whom 21 completed the study through month 12. Tofacitinib was clinically effective by suppressing DAS28-CRP. Glucocorticoids daily dose significantly decreased from baseline. We found a negative correlation between pre-study cumulative and daily dose of glucocorticoids and baseline B-ALP serum levels (r -0.592, p 0.012). Sclerostin serum levels increased significantly during the study period, while P1nP and B-ALP (markers of bone formation) decreased significantly. BMD levels, BHI, MCI and SvdH score did not change. Treatment with tofacitinib was associated with a significant increase in sclerostin serum levels and a parallel decrease in markers of bone formation. However, no significant bone loss was observed.
对接受托法替尼治疗的类风湿性关节炎患者的骨转换标志物(P1nP、B-ALP、CTX)、骨调节剂(Dkk1、硬骨素)和骨密度进行了前瞻性测量。使用托法替尼治疗后,硬骨素明显增加,P1nP和B-ALP(骨形成标志物)明显减少。类风湿性关节炎(RA)的特点是骨质流失。目前尚不清楚 JAK 抑制剂是否能通过调节骨代谢来减轻类风湿性关节炎的骨质流失。我们研究的主要目的是探讨托法替尼对血清中骨转换标志物和调节剂水平的影响。次要目标是评估骨矿物质密度(BMD)、掌骨指数和骨侵蚀的变化。我们对使用 bDMARDs 或 tsDMARDs 治疗失败、开始使用托法替尼治疗的活动性 RA 患者进行了一项前瞻性观察研究。我们在基线及1、2、3、6、9和12个月后测量了血清骨转换标志物(CTX、P1nP、B-ALP)、骨调节剂(Dkk-1、硬骨素、维生素D、PTH、OPG和RANKL)、BMD和放射学参数(夏普-范德海德评分[SvdH]、骨健康指数[BHI]和掌骨指数[MCI])。研究共招募了 30 名患者,其中 21 人完成了第 12 个月的研究。托法替尼通过抑制DAS28-CRP取得了临床疗效。糖皮质激素的日剂量与基线相比明显减少。我们发现,研究前糖皮质激素的累积剂量和日剂量与基线 B-ALP 血清水平呈负相关(r -0.592,p 0.012)。在研究期间,硬骨素血清水平显著上升,而 P1nP 和 B-ALP(骨形成标志物)显著下降。BMD水平、BHI、MCI和SvdH评分没有变化。使用托法替尼治疗后,硬骨素血清水平显著升高,骨形成标志物也同时下降。不过,没有观察到明显的骨质流失。
{"title":"Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis","authors":"Giovanni Adami, Giovanni Orsolini, Maurizio Rossini, Anna Fratucello, Angelo Fassio, Ombretta Viapiana, Elena Fracassi, Riccardo Bixio, Davide Gatti","doi":"10.1186/s41927-024-00414-6","DOIUrl":"https://doi.org/10.1186/s41927-024-00414-6","url":null,"abstract":"Bone turnover makers (P1nP, B-ALP, CTX), bone modulators (Dkk1, sclerostin) and BMD were measured prospectively in rheumatoid arthritis patients treated with tofacitinib. Sclerostin increased significantly after treatment with tofacitinib, P1nP and B-ALP (markers of bone formation) decreased significantly. Rheumatoid arthritis (RA) is characterized by bone loss. It is unclear whether JAK inhibitors can attenuate bone loss in RA by modulating bone metabolism. The main objective of our study is to investigate the effects of tofacitinib on serum levels of bone turnover markers and modulators. Secondary objectives were to assess changes in bone mineral density (BMD), metacarpal index, bone erosions. We conducted a prospective observational study on patients with active RA failure to bDMARDs or tsDMARDs initiating treatment with tofacitinib. We measured at baseline and after 1, 2, 3, 6, 9 and 12 months: serum bone turnover markers (CTX, P1nP, B-ALP), bone modulators (Dkk-1, sclerostin, vitamin D, PTH, OPG and RANKL), BMD and radiographic parameters (Sharp van der Heijde score [SvdH], bone health index [BHI] and metacarpal index [MCI]). 30 patients were enrolled in the study of whom 21 completed the study through month 12. Tofacitinib was clinically effective by suppressing DAS28-CRP. Glucocorticoids daily dose significantly decreased from baseline. We found a negative correlation between pre-study cumulative and daily dose of glucocorticoids and baseline B-ALP serum levels (r -0.592, p 0.012). Sclerostin serum levels increased significantly during the study period, while P1nP and B-ALP (markers of bone formation) decreased significantly. BMD levels, BHI, MCI and SvdH score did not change. Treatment with tofacitinib was associated with a significant increase in sclerostin serum levels and a parallel decrease in markers of bone formation. However, no significant bone loss was observed.","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Rheumatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1